Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 3
1998 4
1999 2
2000 2
2002 2
2004 1
2005 3
2006 4
2007 4
2008 1
2009 2
2010 3
2011 9
2012 12
2013 9
2014 6
2015 5
2016 7
2017 4
2018 3
2019 2
2020 2
2021 6
2022 5
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
Reply.
Callejas JL, Ortego Centeno N. Callejas JL, et al. Med Clin (Barc). 2021 Apr 9;156(7):361. doi: 10.1016/j.medcli.2020.08.015. Epub 2021 Jan 8. Med Clin (Barc). 2021. PMID: 33431181 English, Spanish. No abstract available.
Biologics-induced autoimmune diseases.
Perez-Alvarez R, Pérez-de-Lis M, Ramos-Casals M; BIOGEAS study group. Perez-Alvarez R, et al. Curr Opin Rheumatol. 2013 Jan;25(1):56-64. doi: 10.1097/BOR.0b013e32835b1366. Curr Opin Rheumatol. 2013. PMID: 23114587 Review.
The Effect of Body Fat Distribution on Systemic Sclerosis.
Villanueva-Martin G, Acosta-Herrera M, Kerick M, López-Isac E, Simeón CP, Callejas JL, Assassi S, Beretta L, SSc Group I, Asig ASIG, Allanore Y, Proudman SM, Nikpour M, Fonseca C, Denton CP, Radstake TRDJ, Mayes MD, Jiang X, Martin J, Bossini-Castillo L. Villanueva-Martin G, et al. Among authors: callejas jl. J Clin Med. 2022 Oct 12;11(20):6014. doi: 10.3390/jcm11206014. J Clin Med. 2022. PMID: 36294335 Free PMC article.
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis.
Kerick M, Acosta-Herrera M, Simeón-Aznar CP, Callejas JL, Assassi S; International SSc Group; Proudman SM, Nikpour M; Australian Scleroderma Interest Group (ASIG); PRECISESADS Clinical Consortium; Hunzelmann N, Moroncini G, de Vries-Bouwstra JK, Orozco G, Barton A, Herrick AL, Terao C, Allanore Y, Fonseca C, Alarcón-Riquelme ME, Radstake TRDJ, Beretta L, Denton CP, Mayes MD, Martin J. Kerick M, et al. Among authors: callejas jl. NPJ Genom Med. 2022 Oct 5;7(1):57. doi: 10.1038/s41525-022-00327-8. NPJ Genom Med. 2022. PMID: 36198672 Free PMC article.
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways.
López-Isac E, Acosta-Herrera M, Kerick M, Assassi S, Satpathy AT, Granja J, Mumbach MR, Beretta L, Simeón CP, Carreira P, Ortego-Centeno N, Castellvi I, Bossini-Castillo L, Carmona FD, Orozco G, Hunzelmann N, Distler JHW, Franke A, Lunardi C, Moroncini G, Gabrielli A, de Vries-Bouwstra J, Wijmenga C, Koeleman BPC, Nordin A, Padyukov L, Hoffmann-Vold AM, Lie B; European Scleroderma Group†; Proudman S, Stevens W, Nikpour M; Australian Scleroderma Interest Group (ASIG); Vyse T, Herrick AL, Worthington J, Denton CP, Allanore Y, Brown MA, Radstake TRDJ, Fonseca C, Chang HY, Mayes MD, Martin J. López-Isac E, et al. Nat Commun. 2019 Oct 31;10(1):4955. doi: 10.1038/s41467-019-12760-y. Nat Commun. 2019. PMID: 31672989 Free PMC article.
Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients.
Calderón-Goercke M, Loricera J, Moriano C, Castañeda S, Narváez J, Aldasoro V, Maiz O, Melero R, Villa JI, Vela P, Romero-Yuste S, Callejas JL, de Miguel E, Galíndez-Agirregoikoa E, Sivera F, Fernández-López JC, Galisteo C, Ferraz-Amaro I, Sanchéz-Martín J, Sánchez-Bilbao L, González-Gay MA, Hernández JL, Blanco R; Tocilizumab in Giant Cell Arteritis Spanish Collaborative Group. Calderón-Goercke M, et al. Among authors: callejas jl. Clin Exp Rheumatol. 2023 Apr;41(4):829-836. doi: 10.55563/clinexprheumatol/oqs8u9. Epub 2022 Nov 2. Clin Exp Rheumatol. 2023. PMID: 36377586 Free article.
Biologic therapy in refractory neurobehçet's disease: a multicentre study of 41 patients and literature review.
Herrero-Morant A, Martín-Varillas JL, Castañeda S, Maíz O, Sánchez J, Ortego N, Raya E, Prior-Español Á, Moriano C, Melero-González RB, Graña-Gil J, Urruticoechea-Arana A, Ramos-Calvo Á, Loredo-Martínez M, Salgado-Pérez E, Sivera F, Torre I, Narváez J, Andreu JL, Martínez-González O, Torre RG, Fernández-Aguado S, Romero-Yuste S, González-Mazón Í, Álvarez-Reguera C, Hernández JL, González-Gay MÁ, Blanco R; Neurobehçet Spanish Collaborative Group. Herrero-Morant A, et al. Rheumatology (Oxford). 2022 Nov 2;61(11):4427-4436. doi: 10.1093/rheumatology/keac097. Rheumatology (Oxford). 2022. PMID: 35166821 Review.
Autoimmune diseases induced by biological agents: a double-edged sword?
Ramos-Casals M, Roberto-Perez-Alvarez, Diaz-Lagares C, Cuadrado MJ, Khamashta MA; BIOGEAS Study Group. Ramos-Casals M, et al. Autoimmun Rev. 2010 Jan;9(3):188-93. doi: 10.1016/j.autrev.2009.10.003. Epub 2009 Oct 23. Autoimmun Rev. 2010. PMID: 19854301 Review.
87 results